dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Simon, Marc |
dc.contributor.author | Hanrott, Kate |
dc.contributor.author | Budd, David C |
dc.contributor.author | Torres, Fernando |
dc.contributor.author | Grünig, Ekkehard |
dc.contributor.author | Escribano‐Subias, Pilar |
dc.contributor.author | López Meseguer, Manuel |
dc.date.accessioned | 2022-09-09T13:01:05Z |
dc.date.available | 2022-09-09T13:01:05Z |
dc.date.issued | 2022-01 |
dc.identifier.citation | Simon MA, Hanrott K, Budd DC, Torres F, Grünig E, Escribano-Subias P, et al. An open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arterial hypertension. Pulm Circ. 2022 Jan;12(1):e12024. |
dc.identifier.issn | 2045-8940 |
dc.identifier.uri | https://hdl.handle.net/11351/8122 |
dc.description | Hipertensión arterial; Hemodinámica; Sistema renina-angiotensina |
dc.language.iso | eng |
dc.publisher | Wiley |
dc.relation.ispartofseries | Pulmonary Circulation;12(1) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Hipertensió pulmonar - Tractament |
dc.subject | Farmacocinètica |
dc.subject | Avaluació de resultats (Assistència sanitària) |
dc.subject.mesh | Hypertension, Pulmonary |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Pharmacokinetics |
dc.subject.mesh | Treatment Outcome |
dc.title | An open-label, dose-escalation study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses of GSK2586881 in participants with pulmonary arterial hypertension |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1002/pul2.12024 |
dc.subject.decs | hipertensión pulmonar |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | farmacocinética |
dc.subject.decs | resultado del tratamiento |
dc.relation.publishversion | https://doi.org/10.1002/pul2.12024 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Simon MA] Division of Cardiology, Department of Medicine, University of California, San Francisco, California, USA. [Hanrott K, Budd DC] Research and Development, Medicines Research Centre, GlaxoSmithKline plc., Stevenage, UK. [Torres F] UT Southwestern Medical Center, Dallas, Texas, USA. [Grünig E] Centre for Pulmonary Hypertension, Thoraxklinik Heidelberg gGmbH at Heidelberg University Hospital, Heidelberg, Germany. [Escribano-Subias P] CIBER‐CV Cardiology Department, Pulmonary Hypertension Unit, Hospital Universitario 12 de Octubre, Madrid, Spain. [Meseguer ML] Unitat de Pneumologia, Vall d'Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 35506108 |
dc.identifier.wos | 000773552900001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |